6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
1m ago	Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
2m ago	AnorTech to Receive Cash and Equity from Corporate Transaction on the Sarfartoq Rare Earth Project
2m ago	D. Boral Capital Acted as Exclusive Placement Agent to LanzaTech Global, Inc. (Nasdaq:LNZA) in Connection with its $20,000,000 Registered Direct Offering
2m ago	Bulletin from the Annual General Meeting in Cantargia AB (publ)
4m ago	Centurion Initiates Exploration on Limestone Gold Project

About

0.28EUR-0.02 -5.35%

Closed • Updated at 15:05 GMT+00:00

Market Cap$15.56M

P/E Ratio14.15

Volume19.5K

Beta0.59

RSI40.19

Health TechnologyBiotechnology

Celyad Oncology Sa — investor relations, events, news, and company updates on 6ix.

Latest News

Celyad Oncology Reports Full Year 2025 Financial Results and Business Highlights

Celyad Oncology Announces the Sale of C-CATHez ® Catheter

Celyad Oncology: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad Oncology Announces Research Facility Divestiture

Community Chat

Ask AI